

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.36328305 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.36328305 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.04226685 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.04226685 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.64881856 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.32721387 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.03784723 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.03784723 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.03784723 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.92931710 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.86973874 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.79238421 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 5.70004287 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.67928404 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.65457953 |
| 16 | epoxygenase P450 pathway (GO:0019373) | 5.65056337 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.60280755 |
| 18 | urea metabolic process (GO:0019627) | 5.51626815 |
| 19 | urea cycle (GO:0000050) | 5.51626815 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.49608953 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.37651351 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.34761364 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.33090696 |
| 24 | exogenous drug catabolic process (GO:0042738) | 5.32894916 |
| 25 | cysteine metabolic process (GO:0006534) | 5.31573349 |
| 26 | protein carboxylation (GO:0018214) | 5.31000451 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31000451 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.06636107 |
| 29 | bile acid metabolic process (GO:0008206) | 5.03908321 |
| 30 | regulation of complement activation (GO:0030449) | 5.02629150 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.99964973 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.98966915 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.85596929 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.85224039 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.83572152 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.83572152 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83572152 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.82778059 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79302197 |
| 40 | bile acid and bile salt transport (GO:0015721) | 4.76473765 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.71605165 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.65995076 |
| 43 | drug metabolic process (GO:0017144) | 4.65525134 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.65042574 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.65042574 |
| 46 | phospholipid efflux (GO:0033700) | 4.64651870 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.63102874 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.58042325 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.58042325 |
| 50 | lysine catabolic process (GO:0006554) | 4.51241908 |
| 51 | lysine metabolic process (GO:0006553) | 4.51241908 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.50955223 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.50100670 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.45027064 |
| 55 | cellular glucuronidation (GO:0052695) | 4.35558699 |
| 56 | glycine metabolic process (GO:0006544) | 4.28810584 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.27467282 |
| 58 | omega-hydroxylase P450 pathway (GO:0097267) | 4.25468723 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.24567840 |
| 60 | cholesterol efflux (GO:0033344) | 4.24106488 |
| 61 | imidazole-containing compound metabolic process (GO:0052803) | 4.21689384 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.19296828 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.16767433 |
| 64 | amine catabolic process (GO:0009310) | 4.16767433 |
| 65 | glutamate metabolic process (GO:0006536) | 4.12429728 |
| 66 | oxidative demethylation (GO:0070989) | 4.10448178 |
| 67 | plasma lipoprotein particle assembly (GO:0034377) | 4.08700060 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.08250807 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.06637816 |
| 70 | ethanol oxidation (GO:0006069) | 4.06420373 |
| 71 | fibrinolysis (GO:0042730) | 4.04684214 |
| 72 | ketone body metabolic process (GO:1902224) | 4.03693998 |
| 73 | drug catabolic process (GO:0042737) | 3.99764709 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 3.99572854 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 3.95107865 |
| 76 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95047438 |
| 77 | arginine metabolic process (GO:0006525) | 3.94952394 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.94286175 |
| 79 | alkaloid metabolic process (GO:0009820) | 3.91604739 |
| 80 | blood coagulation, intrinsic pathway (GO:0007597) | 3.90993627 |
| 81 | phospholipid homeostasis (GO:0055091) | 3.90406425 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89704884 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89704884 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.89666603 |
| 85 | uronic acid metabolic process (GO:0006063) | 3.86696041 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.86696041 |
| 87 | cholesterol homeostasis (GO:0042632) | 3.83326874 |
| 88 | sterol homeostasis (GO:0055092) | 3.77020410 |
| 89 | intestinal absorption (GO:0050892) | 3.75893241 |
| 90 | complement activation, classical pathway (GO:0006958) | 3.75618403 |
| 91 | flavonoid metabolic process (GO:0009812) | 3.75578197 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73995453 |
| 93 | protein activation cascade (GO:0072376) | 3.73689444 |
| 94 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73320381 |
| 95 | cytolysis (GO:0019835) | 3.72723998 |
| 96 | complement activation (GO:0006956) | 3.70136760 |
| 97 | regulation of cholesterol homeostasis (GO:2000188) | 3.69787341 |
| 98 | cofactor catabolic process (GO:0051187) | 3.69754214 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.69093004 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.68776232 |
| 101 | protein-lipid complex assembly (GO:0065005) | 3.67454006 |
| 102 | organic acid catabolic process (GO:0016054) | 3.66860182 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.66860182 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.65947457 |
| 105 | regulation of guanylate cyclase activity (GO:0031282) | 3.63624445 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.63490372 |
| 107 | L-fucose catabolic process (GO:0042355) | 3.59385489 |
| 108 | fucose catabolic process (GO:0019317) | 3.59385489 |
| 109 | L-fucose metabolic process (GO:0042354) | 3.59385489 |
| 110 | sulfation (GO:0051923) | 3.56739622 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.54545959 |
| 112 | NAD biosynthetic process (GO:0009435) | 3.52163174 |
| 113 | phenylpropanoid metabolic process (GO:0009698) | 3.50204339 |
| 114 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.32656862 |
| 115 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.26407839 |
| 116 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.21320258 |
| 117 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.21320258 |
| 118 | drug transmembrane transport (GO:0006855) | 3.12329931 |
| 119 | regulation of lipoprotein metabolic process (GO:0050746) | 3.09005865 |
| 120 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.05772863 |
| 121 | positive regulation of fatty acid transport (GO:2000193) | 3.05118473 |
| 122 | vitamin biosynthetic process (GO:0009110) | 3.03473977 |
| 123 | transepithelial transport (GO:0070633) | 3.02769149 |
| 124 | urate metabolic process (GO:0046415) | 3.02624644 |
| 125 | angiotensin maturation (GO:0002003) | 3.02002077 |
| 126 | positive regulation of icosanoid secretion (GO:0032305) | 2.97432013 |
| 127 | sulfate transmembrane transport (GO:1902358) | 2.95978153 |
| 128 | negative regulation of protein activation cascade (GO:2000258) | 2.94259083 |
| 129 | regulation of protein glycosylation (GO:0060049) | 2.94047936 |
| 130 | behavioral response to nicotine (GO:0035095) | 2.91711135 |
| 131 | intestinal cholesterol absorption (GO:0030299) | 2.89625808 |
| 132 | detection of light stimulus involved in visual perception (GO:0050908) | 2.88534834 |
| 133 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.88534834 |
| 134 | indole-containing compound metabolic process (GO:0042430) | 2.88002989 |
| 135 | xenobiotic catabolic process (GO:0042178) | 2.87883251 |
| 136 | heme transport (GO:0015886) | 2.84909723 |
| 137 | S-adenosylmethionine metabolic process (GO:0046500) | 2.83755274 |
| 138 | arginine catabolic process (GO:0006527) | 2.83172945 |
| 139 | reflex (GO:0060004) | 2.80891107 |
| 140 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.80540116 |
| 141 | xenobiotic metabolic process (GO:0006805) | 2.79657767 |
| 142 | ethanol metabolic process (GO:0006067) | 2.79257134 |
| 143 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.76645474 |
| 144 | drug transport (GO:0015893) | 2.70180669 |
| 145 | quinone biosynthetic process (GO:1901663) | 2.69429292 |
| 146 | lipoprotein metabolic process (GO:0042157) | 2.68700712 |
| 147 | negative regulation of complement activation (GO:0045916) | 2.66350615 |
| 148 | behavioral response to ethanol (GO:0048149) | 2.65582469 |
| 149 | thyroid hormone metabolic process (GO:0042403) | 2.64151022 |
| 150 | L-ascorbic acid metabolic process (GO:0019852) | 2.64032260 |
| 151 | tachykinin receptor signaling pathway (GO:0007217) | 2.59593433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.25492380 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14797464 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.90098278 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.37473777 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14968675 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.98820694 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81892752 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93053406 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.80353038 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.07926389 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 3.00478664 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.72048866 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65469669 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.28552351 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21376014 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.21229156 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.12388466 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.10648313 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06410524 |
| 20 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7738820 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.95672868 |
| 22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.93896589 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88472278 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82192783 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.81900017 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78262984 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76679741 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72417672 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.71502196 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69327574 |
| 31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64702507 |
| 32 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.62755915 |
| 33 | STAT3_23295773_ChIP-Seq_U87_Human | 1.60453219 |
| 34 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60141574 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58768771 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58705996 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57584065 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56835650 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54719479 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.52022762 |
| 41 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.52016886 |
| 42 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.50559245 |
| 43 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49619133 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.49610230 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.49610230 |
| 46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.47567850 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47548885 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46915559 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44343093 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44254922 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43012009 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42202751 |
| 53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42158775 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39435159 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39053653 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38395905 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37433996 |
| 58 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36980860 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36980860 |
| 60 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.36894342 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36660916 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30721669 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30613573 |
| 64 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29332545 |
| 65 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29332545 |
| 66 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.28126820 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28124356 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26764191 |
| 69 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23820216 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23783426 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.21887449 |
| 72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21280981 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20491754 |
| 74 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18990400 |
| 75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18663299 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18402146 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17881222 |
| 78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17600537 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17105806 |
| 80 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16835903 |
| 81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16613398 |
| 82 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16118935 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15928544 |
| 84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15851359 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14354693 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14354693 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14154570 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13723673 |
| 89 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12575691 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12531610 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12091898 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11638714 |
| 93 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.10769168 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09648295 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09476499 |
| 96 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09430426 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08837000 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06409144 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06306237 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05463905 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05246407 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04703878 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04609953 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03563102 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03420617 |
| 106 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.02982851 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02458883 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00436440 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95954452 |
| 110 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95222119 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85891589 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83778007 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83342033 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81313386 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79623579 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79104724 |
| 117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78738774 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78531285 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77817675 |
| 120 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77481454 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76504418 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75808620 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74869298 |
| 124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73049565 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73024165 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71079339 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70764686 |
| 128 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70143750 |
| 129 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68989406 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68986503 |
| 131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68392828 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65025809 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65025809 |
| 134 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64256239 |
| 135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.61602267 |
| 136 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60876615 |
| 137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59773107 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59567863 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59178282 |
| 140 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.58992231 |
| 141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57136500 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.56831709 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.56829570 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55636679 |
| 145 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.55561200 |
| 146 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54833457 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53352787 |
| 148 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51898078 |
| 149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.51835040 |
| 150 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50432195 |
| 151 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49548146 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49285306 |
| 153 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.49221683 |
| 154 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49132932 |
| 155 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48817794 |
| 156 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.48602096 |
| 157 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48404744 |
| 158 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.47981093 |
| 159 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47281204 |
| 160 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47113061 |
| 161 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46496736 |
| 162 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46253384 |
| 163 | CBP_21632823_ChIP-Seq_H3396_Human | 0.44843898 |
| 164 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.43887894 |
| 165 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.43738914 |
| 166 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.40494467 |
| 167 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.40126668 |
| 168 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40010693 |
| 169 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39005648 |
| 170 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38918347 |
| 171 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.38807034 |
| 172 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.38229301 |
| 173 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.37346865 |
| 174 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.37224381 |
| 175 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37088407 |
| 176 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36611456 |
| 177 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36436399 |
| 178 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36029247 |
| 179 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.35964510 |
| 180 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35924512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14095355 |
| 2 | MP0005360_urolithiasis | 7.60344149 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37921432 |
| 4 | MP0005365_abnormal_bile_salt | 6.10385436 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10769827 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.30591344 |
| 7 | MP0003252_abnormal_bile_duct | 3.89294964 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60138928 |
| 9 | MP0009840_abnormal_foam_cell | 3.25389073 |
| 10 | MP0005083_abnormal_biliary_tract | 3.02648054 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.78366864 |
| 12 | MP0005332_abnormal_amino_acid | 2.68546856 |
| 13 | MP0003195_calcinosis | 2.67406678 |
| 14 | MP0004043_abnormal_pH_regulation | 2.65014717 |
| 15 | MP0004147_increased_porphyrin_level | 2.49386342 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.44815199 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.23492776 |
| 18 | MP0000609_abnormal_liver_physiology | 2.14110661 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.07629166 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.01685642 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.93786845 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.93063404 |
| 23 | MP0003868_abnormal_feces_composition | 1.92655866 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.82905067 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.63211742 |
| 26 | MP0001764_abnormal_homeostasis | 1.62614987 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 1.59078107 |
| 28 | MP0003878_abnormal_ear_physiology | 1.59078107 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56335787 |
| 30 | MP0009697_abnormal_copulation | 1.56278445 |
| 31 | * MP0001501_abnormal_sleep_pattern | 1.48422181 |
| 32 | MP0001664_abnormal_digestion | 1.47339282 |
| 33 | MP0002102_abnormal_ear_morphology | 1.42885869 |
| 34 | MP0005451_abnormal_body_composition | 1.38534795 |
| 35 | MP0003011_delayed_dark_adaptation | 1.38466586 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.38232886 |
| 37 | MP0000427_abnormal_hair_cycle | 1.32323384 |
| 38 | MP0001485_abnormal_pinna_reflex | 1.31942329 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.31908163 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.31890871 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.27036330 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.27031998 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.25163218 |
| 44 | MP0003186_abnormal_redox_activity | 1.23649172 |
| 45 | MP0003646_muscle_fatigue | 1.21284545 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.19576557 |
| 47 | MP0000538_abnormal_urinary_bladder | 1.18673442 |
| 48 | MP0000598_abnormal_liver_morphology | 1.16459725 |
| 49 | MP0000604_amyloidosis | 1.10502198 |
| 50 | MP0005253_abnormal_eye_physiology | 1.09803706 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.09357345 |
| 52 | MP0005647_abnormal_sex_gland | 1.09115943 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.08531003 |
| 54 | MP0003136_yellow_coat_color | 1.06870444 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.06741191 |
| 56 | MP0003879_abnormal_hair_cell | 1.05028820 |
| 57 | MP0001324_abnormal_eye_pigmentation | 1.03868950 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.02379842 |
| 59 | MP0002254_reproductive_system_inflammat | 1.02184745 |
| 60 | MP0009764_decreased_sensitivity_to | 1.00944558 |
| 61 | MP0002938_white_spotting | 0.98965946 |
| 62 | MP0010368_abnormal_lymphatic_system | 0.96725667 |
| 63 | MP0001968_abnormal_touch/_nociception | 0.96233128 |
| 64 | MP0003950_abnormal_plasma_membrane | 0.96056014 |
| 65 | MP0009763_increased_sensitivity_to | 0.96055990 |
| 66 | MP0002638_abnormal_pupillary_reflex | 0.95397854 |
| 67 | MP0008469_abnormal_protein_level | 0.89003816 |
| 68 | MP0003866_abnormal_defecation | 0.88375220 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 0.88344490 |
| 70 | MP0009642_abnormal_blood_homeostasis | 0.87521426 |
| 71 | MP0000383_abnormal_hair_follicle | 0.87454397 |
| 72 | MP0002822_catalepsy | 0.87155014 |
| 73 | MP0005646_abnormal_pituitary_gland | 0.84229806 |
| 74 | MP0008775_abnormal_heart_ventricle | 0.84139233 |
| 75 | MP0005408_hypopigmentation | 0.83284193 |
| 76 | MP0009053_abnormal_anal_canal | 0.83007661 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.82514926 |
| 78 | MP0010155_abnormal_intestine_physiology | 0.82348663 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.79715611 |
| 80 | MP0005410_abnormal_fertilization | 0.78462081 |
| 81 | MP0004885_abnormal_endolymph | 0.77749835 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 0.77281063 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.76900285 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.76327003 |
| 85 | MP0009745_abnormal_behavioral_response | 0.75890513 |
| 86 | MP0006072_abnormal_retinal_apoptosis | 0.74742964 |
| 87 | MP0005195_abnormal_posterior_eye | 0.74382521 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.73686473 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.73570531 |
| 90 | MP0000566_synostosis | 0.73346028 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.71153238 |
| 92 | MP0006276_abnormal_autonomic_nervous | 0.71121112 |
| 93 | MP0004142_abnormal_muscle_tone | 0.70864854 |
| 94 | MP0002971_abnormal_brown_adipose | 0.68477010 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.68178185 |
| 96 | MP0005670_abnormal_white_adipose | 0.67184339 |
| 97 | MP0001486_abnormal_startle_reflex | 0.67106708 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.66552993 |
| 99 | MP0004924_abnormal_behavior | 0.66552993 |
| 100 | MP0006054_spinal_hemorrhage | 0.66482451 |
| 101 | MP0005266_abnormal_metabolism | 0.66219128 |
| 102 | MP0000371_diluted_coat_color | 0.66070814 |
| 103 | MP0001661_extended_life_span | 0.65426242 |
| 104 | MP0001756_abnormal_urination | 0.64590042 |
| 105 | MP0002272_abnormal_nervous_system | 0.63767142 |
| 106 | MP0002229_neurodegeneration | 0.63366270 |
| 107 | MP0005334_abnormal_fat_pad | 0.63293058 |
| 108 | MP0002168_other_aberrant_phenotype | 0.62616155 |
| 109 | MP0005535_abnormal_body_temperature | 0.61708944 |
| 110 | MP0004130_abnormal_muscle_cell | 0.61645386 |
| 111 | MP0000516_abnormal_urinary_system | 0.61502128 |
| 112 | MP0005367_renal/urinary_system_phenotyp | 0.61502128 |
| 113 | MP0003690_abnormal_glial_cell | 0.61343874 |
| 114 | MP0004484_altered_response_of | 0.60556015 |
| 115 | MP0010678_abnormal_skin_adnexa | 0.60267058 |
| 116 | MP0005389_reproductive_system_phenotype | 0.60042046 |
| 117 | MP0003329_amyloid_beta_deposits | 0.59411638 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.57966566 |
| 119 | MP0005448_abnormal_energy_balance | 0.54152095 |
| 120 | MP0004264_abnormal_extraembryonic_tissu | 0.54049266 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.52684096 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.52490882 |
| 123 | MP0002796_impaired_skin_barrier | 0.50830878 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.48910211 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.48538813 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.46619289 |
| 127 | MP0008873_increased_physiological_sensi | 0.46525293 |
| 128 | MP0005395_other_phenotype | 0.44624798 |
| 129 | MP0003075_altered_response_to | 0.44606677 |
| 130 | MP0005166_decreased_susceptibility_to | 0.43757513 |
| 131 | MP0003718_maternal_effect | 0.42888454 |
| 132 | MP0008874_decreased_physiological_sensi | 0.42274373 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.41058558 |
| 134 | MP0008872_abnormal_physiological_respon | 0.41005629 |
| 135 | MP0009384_cardiac_valve_regurgitation | 0.40654449 |
| 136 | MP0003724_increased_susceptibility_to | 0.40594240 |
| 137 | MP0003953_abnormal_hormone_level | 0.40279003 |
| 138 | MP0002928_abnormal_bile_duct | 0.38858991 |
| 139 | MP0003436_decreased_susceptibility_to | 0.38682505 |
| 140 | MP0000579_abnormal_nail_morphology | 0.37948156 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.37113610 |
| 142 | MP0005248_abnormal_Harderian_gland | 0.37030986 |
| 143 | MP0002837_dystrophic_cardiac_calcinosis | 0.35289991 |
| 144 | MP0004381_abnormal_hair_follicle | 0.35057499 |
| 145 | MP0000249_abnormal_blood_vessel | 0.33533888 |
| 146 | MP0004883_abnormal_blood_vessel | 0.33285089 |
| 147 | MP0006082_CNS_inflammation | 0.33152200 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.32062839 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.31503552 |
| 150 | MP0001243_abnormal_dermal_layer | 0.31315457 |
| 151 | MP0001845_abnormal_inflammatory_respons | 0.29526506 |
| 152 | MP0009115_abnormal_fat_cell | 0.28757482 |
| 153 | MP0001881_abnormal_mammary_gland | 0.28346680 |
| 154 | MP0002132_abnormal_respiratory_system | 0.28101070 |
| 155 | MP0003453_abnormal_keratinocyte_physiol | 0.27796660 |
| 156 | MP0005164_abnormal_response_to | 0.27436132 |
| 157 | MP0002060_abnormal_skin_morphology | 0.27403370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.44304292 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.40426302 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.17333073 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.55860845 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.54827184 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.34657730 |
| 7 | Xanthomatosis (HP:0000991) | 6.26279398 |
| 8 | Complement deficiency (HP:0004431) | 5.48450129 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.41338876 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.82562517 |
| 11 | Joint hemorrhage (HP:0005261) | 4.79905402 |
| 12 | Hyperammonemia (HP:0001987) | 4.55294926 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44431183 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39860226 |
| 15 | Hyperglycinemia (HP:0002154) | 4.37820487 |
| 16 | Epidermoid cyst (HP:0200040) | 4.35896215 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.23644864 |
| 18 | Fat malabsorption (HP:0002630) | 4.23036268 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18253812 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16331234 |
| 21 | Ketosis (HP:0001946) | 4.09199424 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.08779076 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.03235792 |
| 24 | Abnormality of complement system (HP:0005339) | 4.00616840 |
| 25 | Hyperglycinuria (HP:0003108) | 3.90366593 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85726098 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.85726098 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.83081930 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79826657 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77579519 |
| 31 | Hyperventilation (HP:0002883) | 3.71411897 |
| 32 | Decreased circulating renin level (HP:0003351) | 3.71291574 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.62995907 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.51994867 |
| 35 | Congenital sensorineural hearing impairment (HP:0008527) | 3.36850833 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.31865007 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30550676 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30120700 |
| 39 | Pancreatic cysts (HP:0001737) | 3.26384118 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 3.22616255 |
| 41 | Spontaneous abortion (HP:0005268) | 3.15580622 |
| 42 | Steatorrhea (HP:0002570) | 3.14568767 |
| 43 | Congenital stationary night blindness (HP:0007642) | 3.13581032 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.99319923 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.97584283 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.95175140 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.94105877 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.93398507 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.91039228 |
| 50 | Myocardial infarction (HP:0001658) | 2.87933611 |
| 51 | Ketoacidosis (HP:0001993) | 2.87299044 |
| 52 | Abnormality of vitamin B metabolism (HP:0004340) | 2.83380234 |
| 53 | Pigmentary retinal degeneration (HP:0001146) | 2.81836064 |
| 54 | Chronic hepatic failure (HP:0100626) | 2.75340286 |
| 55 | Metabolic acidosis (HP:0001942) | 2.75117655 |
| 56 | Glycosuria (HP:0003076) | 2.74100224 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.74100224 |
| 58 | True hermaphroditism (HP:0010459) | 2.73931586 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.73738261 |
| 60 | Acanthocytosis (HP:0001927) | 2.72808594 |
| 61 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.71523009 |
| 62 | Metabolic alkalosis (HP:0200114) | 2.69834893 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.68338540 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.67481931 |
| 65 | Proximal tubulopathy (HP:0000114) | 2.66977033 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.65850153 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.65850153 |
| 68 | Skin nodule (HP:0200036) | 2.65377643 |
| 69 | Molar tooth sign on MRI (HP:0002419) | 2.61835931 |
| 70 | Abnormality of midbrain morphology (HP:0002418) | 2.61835931 |
| 71 | Ileus (HP:0002595) | 2.59850606 |
| 72 | Potter facies (HP:0002009) | 2.59741070 |
| 73 | Facial shape deformation (HP:0011334) | 2.59741070 |
| 74 | Tubular atrophy (HP:0000092) | 2.59555292 |
| 75 | Lethargy (HP:0001254) | 2.59315328 |
| 76 | Abolished electroretinogram (ERG) (HP:0000550) | 2.56781531 |
| 77 | Abnormality of renin-angiotensin system (HP:0000847) | 2.56128801 |
| 78 | Stomach cancer (HP:0012126) | 2.55080425 |
| 79 | Vascular calcification (HP:0004934) | 2.54444760 |
| 80 | Fair hair (HP:0002286) | 2.53952029 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 2.53920718 |
| 82 | Hyperalaninemia (HP:0003348) | 2.53920718 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.53920718 |
| 84 | Gaze-evoked nystagmus (HP:0000640) | 2.49518082 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.46024124 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45698033 |
| 87 | Gout (HP:0001997) | 2.45580983 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.44191398 |
| 89 | Hypothermia (HP:0002045) | 2.42329827 |
| 90 | Glomerulonephritis (HP:0000099) | 2.42305385 |
| 91 | Type II lissencephaly (HP:0007260) | 2.39577621 |
| 92 | Cerebral edema (HP:0002181) | 2.39508725 |
| 93 | Cholelithiasis (HP:0001081) | 2.38995429 |
| 94 | Spastic diplegia (HP:0001264) | 2.37243514 |
| 95 | Malnutrition (HP:0004395) | 2.35139840 |
| 96 | Neonatal onset (HP:0003623) | 2.34103635 |
| 97 | Amyloidosis (HP:0011034) | 2.33883602 |
| 98 | Cholecystitis (HP:0001082) | 2.33832519 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 2.33832519 |
| 100 | Large for gestational age (HP:0001520) | 2.33589705 |
| 101 | Esophageal varix (HP:0002040) | 2.32568953 |
| 102 | Irritability (HP:0000737) | 2.30859543 |
| 103 | Gingival bleeding (HP:0000225) | 2.28213561 |
| 104 | Abnormality of macular pigmentation (HP:0008002) | 2.27131930 |
| 105 | Abnormality of the renal medulla (HP:0100957) | 2.26299645 |
| 106 | Mitral stenosis (HP:0001718) | 2.25536490 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.25175325 |
| 108 | Nephronophthisis (HP:0000090) | 2.23091503 |
| 109 | Sensorimotor neuropathy (HP:0007141) | 2.22943460 |
| 110 | Confusion (HP:0001289) | 2.20582790 |
| 111 | Generalized hypopigmentation of hair (HP:0011358) | 2.19579827 |
| 112 | Hyperactive renin-angiotensin system (HP:0000841) | 2.19370452 |
| 113 | Pancreatitis (HP:0001733) | 2.17608615 |
| 114 | Chronic diarrhea (HP:0002028) | 2.15379236 |
| 115 | Menorrhagia (HP:0000132) | 2.15229067 |
| 116 | Cystic liver disease (HP:0006706) | 2.14916549 |
| 117 | Late onset (HP:0003584) | 2.14862896 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 2.14116570 |
| 119 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.13989077 |
| 120 | Pendular nystagmus (HP:0012043) | 2.13962933 |
| 121 | Thrombophlebitis (HP:0004418) | 2.09097277 |
| 122 | Poikilocytosis (HP:0004447) | 2.08908024 |
| 123 | Enlarged kidneys (HP:0000105) | 2.08315981 |
| 124 | Decreased central vision (HP:0007663) | 2.07433858 |
| 125 | Chorioretinal atrophy (HP:0000533) | 2.07027793 |
| 126 | Abnormal biliary tract physiology (HP:0012439) | 2.06223418 |
| 127 | Bile duct proliferation (HP:0001408) | 2.06223418 |
| 128 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.06199615 |
| 129 | Vomiting (HP:0002013) | 2.05777064 |
| 130 | Abnormality of the fovea (HP:0000493) | 2.05453932 |
| 131 | Brushfield spots (HP:0001088) | 2.04518312 |
| 132 | Abnormality of the gallbladder (HP:0005264) | 2.02468420 |
| 133 | Macular degeneration (HP:0000608) | 2.01202819 |
| 134 | Medial flaring of the eyebrow (HP:0010747) | 2.00495638 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.98604466 |
| 136 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97439362 |
| 137 | Generalized aminoaciduria (HP:0002909) | 1.97352842 |
| 138 | Opisthotonus (HP:0002179) | 1.97046788 |
| 139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96781908 |
| 140 | Rickets (HP:0002748) | 1.94955826 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.94881654 |
| 142 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91740832 |
| 143 | Hyperaldosteronism (HP:0000859) | 1.89877041 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88792652 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 1.88741726 |
| 146 | Abnormality of proline metabolism (HP:0010907) | 1.88339027 |
| 147 | Hydroxyprolinuria (HP:0003080) | 1.88339027 |
| 148 | Keratoconus (HP:0000563) | 1.86190848 |
| 149 | Increased corneal curvature (HP:0100692) | 1.86190848 |
| 150 | Abnormal albumin level (HP:0012116) | 1.85460455 |
| 151 | Hypoalbuminemia (HP:0003073) | 1.85460455 |
| 152 | Progressive inability to walk (HP:0002505) | 1.84945159 |
| 153 | Genetic anticipation (HP:0003743) | 1.84564353 |
| 154 | Inability to walk (HP:0002540) | 1.84305887 |
| 155 | Alkalosis (HP:0001948) | 1.84145349 |
| 156 | Hypokalemia (HP:0002900) | 1.83491411 |
| 157 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83375243 |
| 158 | Furrowed tongue (HP:0000221) | 1.82843517 |
| 159 | Abnormality of vitamin metabolism (HP:0100508) | 1.80618049 |
| 160 | Hypophosphatemic rickets (HP:0004912) | 1.78076597 |
| 161 | Renal cortical cysts (HP:0000803) | 1.77742956 |
| 162 | Elevated hepatic transaminases (HP:0002910) | 1.76507845 |
| 163 | Nephritis (HP:0000123) | 1.72810839 |
| 164 | Hyperuricemia (HP:0002149) | 1.69221870 |
| 165 | Increased purine levels (HP:0004368) | 1.69221870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.56180675 |
| 2 | TAOK3 | 5.18764222 |
| 3 | ACVR1B | 4.77391385 |
| 4 | ERN1 | 4.34184748 |
| 5 | FGFR4 | 4.24419050 |
| 6 | SIK1 | 4.05111911 |
| 7 | ADRBK2 | 3.64553520 |
| 8 | ERBB4 | 2.87191560 |
| 9 | MST1R | 2.85501362 |
| 10 | INSRR | 2.59124425 |
| 11 | BMPR1B | 2.40412830 |
| 12 | STK39 | 2.33267518 |
| 13 | MAP2K4 | 2.06166573 |
| 14 | ZAK | 2.04838305 |
| 15 | WNK3 | 2.02032070 |
| 16 | OXSR1 | 1.99510330 |
| 17 | NUAK1 | 1.97112175 |
| 18 | PKN2 | 1.96649860 |
| 19 | CASK | 1.95365521 |
| 20 | MAP4K2 | 1.94765213 |
| 21 | WNK4 | 1.92191759 |
| 22 | MAPK11 | 1.90911580 |
| 23 | FRK | 1.81774547 |
| 24 | PIK3CG | 1.73530065 |
| 25 | PTK6 | 1.67905191 |
| 26 | TRIB3 | 1.65783520 |
| 27 | FLT3 | 1.59071266 |
| 28 | TYK2 | 1.58544639 |
| 29 | LATS1 | 1.48236358 |
| 30 | GRK6 | 1.46060122 |
| 31 | RIPK1 | 1.41540894 |
| 32 | ABL2 | 1.38649263 |
| 33 | DAPK2 | 1.35513869 |
| 34 | NEK9 | 1.32237124 |
| 35 | MST4 | 1.28554077 |
| 36 | ADRBK1 | 1.28076956 |
| 37 | TBK1 | 1.26842213 |
| 38 | KDR | 1.23825263 |
| 39 | TNIK | 1.22195694 |
| 40 | AKT3 | 1.21962536 |
| 41 | PRKCE | 1.14033291 |
| 42 | PIK3CA | 1.13714766 |
| 43 | MAP3K7 | 1.12078849 |
| 44 | JAK2 | 1.10880707 |
| 45 | MET | 1.10477820 |
| 46 | ERBB2 | 1.09352223 |
| 47 | MAPK13 | 1.09196955 |
| 48 | MAP3K14 | 1.08493626 |
| 49 | FGFR2 | 1.08075589 |
| 50 | MAP3K4 | 1.04946093 |
| 51 | PRKAA2 | 1.04824963 |
| 52 | MAP2K3 | 1.02394788 |
| 53 | FER | 1.02322354 |
| 54 | LMTK2 | 1.01601976 |
| 55 | TXK | 1.01525293 |
| 56 | MAP3K10 | 0.98239446 |
| 57 | STK3 | 0.94520517 |
| 58 | MAP3K3 | 0.94257163 |
| 59 | EPHB2 | 0.92388686 |
| 60 | NLK | 0.91693628 |
| 61 | EPHB1 | 0.91527570 |
| 62 | TEC | 0.91119050 |
| 63 | MAP3K11 | 0.89538690 |
| 64 | EPHA2 | 0.88716938 |
| 65 | MAP2K2 | 0.87110666 |
| 66 | MAPK4 | 0.86385542 |
| 67 | IRAK1 | 0.84504173 |
| 68 | JAK1 | 0.84315706 |
| 69 | PTK2 | 0.83063153 |
| 70 | MKNK2 | 0.82553239 |
| 71 | PDK2 | 0.82258829 |
| 72 | PRKCZ | 0.82010247 |
| 73 | PINK1 | 0.81647198 |
| 74 | MAP3K12 | 0.81639624 |
| 75 | TLK1 | 0.81557837 |
| 76 | TGFBR1 | 0.80387292 |
| 77 | CAMKK2 | 0.79429302 |
| 78 | CAMK2G | 0.75020774 |
| 79 | CSK | 0.73886625 |
| 80 | TIE1 | 0.73820681 |
| 81 | PRKACG | 0.72846428 |
| 82 | MAPK15 | 0.72487062 |
| 83 | MUSK | 0.70193389 |
| 84 | STK24 | 0.70153062 |
| 85 | STK38L | 0.69495809 |
| 86 | MAPK12 | 0.69487326 |
| 87 | BRSK2 | 0.69082176 |
| 88 | PTK2B | 0.68661935 |
| 89 | CDK6 | 0.67273845 |
| 90 | PDPK1 | 0.65514006 |
| 91 | MAP2K1 | 0.64009385 |
| 92 | MAP2K6 | 0.63695720 |
| 93 | IKBKE | 0.62511194 |
| 94 | MAPKAPK3 | 0.61890107 |
| 95 | GSK3A | 0.61858664 |
| 96 | ICK | 0.61777701 |
| 97 | EPHA3 | 0.60671458 |
| 98 | DYRK1B | 0.60184796 |
| 99 | PRKAA1 | 0.59320698 |
| 100 | BCR | 0.57694096 |
| 101 | NTRK3 | 0.56838831 |
| 102 | CSNK1A1L | 0.56195455 |
| 103 | TRPM7 | 0.55902959 |
| 104 | IKBKB | 0.52497775 |
| 105 | TAOK2 | 0.51043439 |
| 106 | PRKCQ | 0.50739427 |
| 107 | CSNK1G2 | 0.48736628 |
| 108 | CAMK1D | 0.48612591 |
| 109 | TGFBR2 | 0.48554504 |
| 110 | PHKG1 | 0.48407782 |
| 111 | PHKG2 | 0.48407782 |
| 112 | SGK3 | 0.47207485 |
| 113 | CAMK2A | 0.46708665 |
| 114 | GRK1 | 0.46701045 |
| 115 | PRKACA | 0.46183696 |
| 116 | KIT | 0.45576607 |
| 117 | MAPK7 | 0.44955169 |
| 118 | MAP3K13 | 0.43829758 |
| 119 | PRKCI | 0.43473646 |
| 120 | IRAK3 | 0.43253930 |
| 121 | GRK5 | 0.43130126 |
| 122 | MAP3K1 | 0.42809517 |
| 123 | CSF1R | 0.42196446 |
| 124 | PKN1 | 0.41936348 |
| 125 | CHUK | 0.41543160 |
| 126 | PDK1 | 0.41358874 |
| 127 | IGF1R | 0.40634980 |
| 128 | CSNK1G3 | 0.40202307 |
| 129 | KSR2 | 0.39722363 |
| 130 | CSNK1A1 | 0.39541615 |
| 131 | GRK7 | 0.39377221 |
| 132 | MAP3K2 | 0.38912278 |
| 133 | FGFR3 | 0.37981438 |
| 134 | RET | 0.37507095 |
| 135 | MAPKAPK5 | 0.37081043 |
| 136 | MAP3K5 | 0.36672367 |
| 137 | MATK | 0.34379580 |
| 138 | EGFR | 0.32463746 |
| 139 | TRIM28 | 0.32270631 |
| 140 | PRKCA | 0.31847670 |
| 141 | PRKG1 | 0.31399412 |
| 142 | TAOK1 | 0.31363423 |
| 143 | MTOR | 0.30983698 |
| 144 | PRKCG | 0.30276314 |
| 145 | CSNK1G1 | 0.29925123 |
| 146 | ERBB3 | 0.29813546 |
| 147 | SGK494 | 0.29519132 |
| 148 | SGK223 | 0.29519132 |
| 149 | EPHA4 | 0.28568539 |
| 150 | TNK2 | 0.28471649 |
| 151 | MAP2K7 | 0.28219336 |
| 152 | EIF2AK3 | 0.27842972 |
| 153 | PRKCB | 0.27793500 |
| 154 | MYLK | 0.27375029 |
| 155 | SGK2 | 0.26469926 |
| 156 | PRKG2 | 0.25424266 |
| 157 | PBK | 0.23320545 |
| 158 | PAK3 | 0.21511427 |
| 159 | CDK4 | 0.21010605 |
| 160 | PDGFRA | 0.20496987 |
| 161 | ITK | 0.18299894 |
| 162 | BMX | 0.17632653 |
| 163 | CAMK4 | 0.16941502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.49181261 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53656603 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35172434 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23670409 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99660499 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79944954 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68968213 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64677798 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53284321 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50668925 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46184073 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39795495 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23896804 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20106464 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18130764 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.02834057 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99598383 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96256141 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92687040 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87846981 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86917136 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83390472 |
| 23 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82278603 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.79350325 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78150976 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75129998 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73758099 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73201662 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72671223 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69989912 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68389432 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65863065 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65326127 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.58462539 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55581060 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53906366 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45977959 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42417264 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41820826 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32964408 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31052833 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29520612 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29390710 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28729990 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24650185 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19413033 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.16931967 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14770274 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12494797 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11959120 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09815133 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05250142 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 1.04180166 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98143946 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97328456 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96869455 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95627281 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94772796 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91197857 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87672262 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87182680 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84863528 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81042247 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79475915 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.73845968 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71589944 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70325754 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69851523 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69752084 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68754840 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62907290 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61029070 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56050405 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47887955 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47007285 |
| 76 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46727011 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45945090 |
| 78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45311426 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.43126819 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.39794216 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.35488650 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35399418 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34813041 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33301256 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32769029 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32544242 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.29844095 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24914476 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24745780 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.21813678 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20118719 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.19954008 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19364175 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18884674 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15326518 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14726513 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.13970835 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.10377834 |
| 99 | Morphine addiction_Homo sapiens_hsa05032 | 0.09827589 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09063609 |
| 101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.07697311 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04906948 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02991055 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02525211 |
| 105 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2246140 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.2122104 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2026686 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | -0.1942808 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1903974 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1777592 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1754582 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1618517 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1383111 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1356542 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | -0.1323911 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1277211 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1261738 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1235143 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1231979 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1208705 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1144893 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1142183 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | -0.1101919 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0112012 |

